Mike Hennessy Sr

The unsung heroes of the coronavirus disease 2019 (COVID-19) pandemic are pharmacy technicians.

Higher dietary intake of flavonols may be associated with a lower risk of developing Alzheimer dementia.

These counseling points for your patients are particularly important, as the FDA has not approved any drugs or treatments for mild cognitive impairment.

As the most accessible health care providers, pharmacists can play a key role in counseling patients on the best practices for infection control and prevention.

As Andrew J. Donnelly, PharmD, MBA, FASHP, the director of pharmacy at the University of Illinois Hospital and Health Sciences System in Chicago and a clinical professor and the associate dean for clinical affairs at the University of Illinois at Chicago College of Pharmacy, reports in our cover feature, this year’s hot topics included medication shortages, rising drug prices, legislation, a new gene therapy, the opioid epidemic, and the proliferation of cannabidiol products.

’Tis the season for cold and flu, as we enter that time of year when patients turn to pharmacists for guidance on self-care products for treating these scourges of winter.

The annual NASP conference has become a can't-miss event for specialty stakeholders to stay on top of rapid developments in the field.

Regular visitors to our daily news website may have been surprised by some radical changes to our online home last month, as the Pharmacy Times® site was merged with its sister publication, Specialty Pharmacy Times®.

For most of you and for us here at MJH Life Sciences™, this time of year means conference season.

https://pharmacytimes.com/peer-exchange/the-progression-of-immunization-At its meeting in June, the ACIP made some very interesting suggestions, noting that all children and adolescents between ages 2 and 18 who have not previously received the hepatitis A vaccine should receive a catch-up vaccination and encouraging a change in the human papillomavirus vaccination guidelines to cover men up to age 26.

Within this evolving new world of health care are the questions surrounding the future of smaller independent pharmacies.

Throughout the meeting rooms and educational sessions at the Asembia Specialty Pharmacy Summit 2019, there were clear signs that massive change could alter the industry before next year’s meeting.

Welcome to the ninth annual Specialty Pharmacy Times oncology issue, in which we focus on the challenges and progress associated with treating cancer in the specialty space.

With the first few months of 2019 behind us, one of the signature events in the specialty space is on the horizon.

Following a year in which nearly 40 specialty drugs were approved by the FDA, 2019 also is expected to be huge in the specialty market, with more therapies for cancer, multiple sclerosis, and orphan conditions on the horizon.

In this issue of Specialty Pharmacy Times®, we highlight the goings-on at the National Association of Specialty Pharmacy Annual Meeting and Educational Conference along with some key trends to monitor closely in the year ahead.

There is no doubt that aggressive actions must be taken throughout the US health care landscape to rein in spending on prescription drugs and help patients to access lifesaving therapies.

With drugs that achieve similar clinical outcomes, it will ultimately come down to financial differentiation that can determine which drugs lead the market.

As industry leaders converged on the largest annual conference focused on specialty pharmacy, issues surrounding value dominated the conversations at the Asembia Specialty Pharmacy Summit 2018.

The lifetime probability of developing cancer is 38% for women and 42% for men, which translates into millions of individuals who need the latest information on this disease, as well as compassionate care and counseling

In “The Unusual Discovery of 10 Commonly Prescribed Medications” on pharmacytimes.com, Pharmacy Times® contributor Timothy O’Shea, PharmD, highlights the phenomenon of serendipity (ie, finding something surprising while looking for something else) in the process of drug discovery.